Skip to main content
. 2021 Nov 5;11:770565. doi: 10.3389/fonc.2021.770565

Figure 2.

Figure 2

ImmuneScore is correlated with survival of kidney renal clear cell carcinoma (KIRC) patients and clinical TNM staging. (A–C) According to the ESTIMATE algorithm, survival analysis of high and low ImmuneScore, StromalScore, and ESTIMATEScore. Panels (D–F) show the bar plot of the three scores with tumor clinical staging and TNM staging, respectively.